Published in Cancer Res on December 01, 1971
Follicular origin of epidermal papillomas in v-Ha-ras transgenic TG.AC mouse skin. Proc Natl Acad Sci U S A (1994) 0.98
Cytotoxic properties of the eosinophil major basic protein. J Immunol (1979) 3.29
Immunization with skin isografts taken from tolerant mice. Science (1967) 2.05
Long-term follow-up after partial removal of a solitary kidney. N Engl J Med (1991) 1.99
Which T cells mediate allograft rejection? Transplantation (1985) 1.21
Differential survival of skin and heart allografts in radiation chimaeras provides further evidence for Sk histocompatibility antigen. Nature (1974) 1.20
The survival of skin allografts and xenografts in germ-free mice. Transplantation (1972) 1.09
Cloned LYT-2+ cytolytic T lymphocytes destroy allogeneic tissue in vivo. J Exp Med (1984) 1.07
Passenger leukocytes and induction of allograft immunity. Transplant Proc (1971) 1.06
Transplantation biology and immunogenetics of murine skin-specific (Sk) alloantigens. Transplant Proc (1980) 0.98
Detrimental effect of cyclosporine on initial function of cadaver renal allografts following extended preservation. Results of a randomized prospective study. Transplantation (1986) 0.94
The use of freshly explanted mouse epidermal cells for the in vitro induction and detection of cell-mediated cytotoxicity. Cell Immunol (1976) 0.89
Participation of H-2 regions in heart-transplant rejection. Transplantation (1976) 0.87
Allograft immunity produced with skin isografts from immunologically tolerant mice. Transplant Proc (1969) 0.86
Long-term results of renal transplantation in recipients with a functioning graft for 2 years. Transplantation (1982) 0.86
Differential survival of heart and skin allografts in inbred rats. Transplant Proc (1973) 0.86
In vitro and in vivo cytotoxicity of T cells cloned from rejecting allografts. Transplantation (1986) 0.84
Passenger leukocytes and the immunogenicity of skin allografts. J Invest Dermatol (1980) 0.84
Prolongation of rat heart allografts by donor pretreatment with immunosuppressive agents. Transplant Proc (1971) 0.84
Alternative immunosuppressive strategies in the management of recipients of living related renal transplants. Transplant Proc (1989) 0.83
Renal transplantation in the older recipient. J Urol (1985) 0.83
Effect of cyclosporine upon the function of ischemically damaged kidneys in the rat. Transplantation (1986) 0.82
Cross-species transplantation in embryonic and neonatal animals. Transplant Proc (1970) 0.82
Skin grafting. Methods Enzymol (1984) 0.81
Nonspecific tissue destruction as a consequence of cytotoxic T lymphocyte interaction with antigen-specific target cells. Transplant Proc (1987) 0.81
Lysis of mouse macrophages, fibroblasts, and epidermal cells by epidermal alloantigen-specific cytotoxic T lymphocytes: effect of culture and inflammatory agents on Epa-1 expression. Cell Immunol (1984) 0.79
Renal transplantation for end-stage polycystic kidney disease. Urology (1987) 0.79
Late ureteral obstruction and hematuria from de novo angiosarcoma in a renal transplant patient. J Urol (1980) 0.79
The older living renal donor: prognosis for the donor and recipient. J Urol (1980) 0.79
Passenger leukocytes and the immunogenicity of skin allografts: a critical reevaluation. Transplant Proc (1981) 0.79
Cell-mediated cytotoxicity to non-MHC alloantigens on mouse epidermal cells. I. H-2 restricted reactions among strains sharing the H-2k haplotype. J Immunol (1981) 0.79
Prolonged survival of rat heart and kidney allografts irradiated in vitro. Transplantation (1971) 0.79
Functional capacity and rehabilitation of recipients with a functioning renal allograft for ten years or more. Transplantation (1983) 0.78
Coronary arteriography and coronary artery disease in 99 diabetic and nondiabetic patients on chronic hemodialysis or renal transplantation programs. Transplant Proc (1981) 0.78
Establishment of cytolytic T lymphocyte clones to epidermal alloantigen Epa-1. Transplantation (1982) 0.78
Improved results of cadaver renal transplantation with azathioprine, prednisone and antilymphoblast globulin. J Urol (1984) 0.78
Acute rejection of skin and heart allografts in rats matched at the major rat histocompatibility locus. Transplantation (1969) 0.78
Serum-blocking factors versus specific cellular tolerance in long-term survival of rat heart allografts. Transplantation (1976) 0.78
Cell-mediated cytotoxicity to non-MHC alloantigens on mouse epidermal cells. IV. An alloantigen shared with B cells but not T cells. Cell Immunol (1982) 0.78
The phenomenon of adaptation: graft or host? Transplant Proc (1973) 0.78
Studies on immune lymphocyte transfer reactions in murine homologous cell chimeras. Transplantation (1970) 0.78
Blocking of interleukin-2 production, but not the tissue destruction induced by cytotoxic T cells, by cyclosporine. Transplantation (1989) 0.78
The "Sk" (skin-specific) rejection phenomenon as evidence of the natural role of acquired tolerance. Transplant Proc (1977) 0.77
Treatment of hereditary spherocytosis in Peromyscus by radiation and allogeneic bone marrow transplantation. Blood (1967) 0.77
The outcome of renal transplantation in children without prolonged pre-transplant dialysis. Clin Pediatr (Phila) (1991) 0.77
Augmentation of cell-mediated cytotoxicity by short-term in vitro precultivation of effector cells. Transplant Proc (1979) 0.77
Epidermal alloantigen and the survival of mouse skin allografts. Transplantation (1982) 0.76
Renal transplantation in end stage renal disease patients with existing urinary diversion. J Urol (1986) 0.76
Renal computed tomography with 3-dimensional angiography and simultaneous measurement of plasma contrast clearance reduce the invasiveness and cost of evaluating living renal donor candidates. Transplantation (1996) 0.76
Suppressor cells and transplantation tolerance. Transplantation (1978) 0.76
Nerve xenografts to apportion the role of axon and Schwann cell in myelinated fiber absence in hereditary sensory neuropathy, type II. Neurology (1979) 0.76
Graft-versus-host reactions. Methods Enzymol (1984) 0.76
Survival of neonatal mouse epidermal allografts. Transplantation (1990) 0.75
Improved results of cadaver renal transplantation in the diabetic patient. J Urol (1983) 0.75
Improved cadaver allograft survival in transfused recipients who remain serologically negative for cytomegalovirus. J Urol (1982) 0.75
Failure to confirm the prolonged survival of rat kidney allografts perfused with concanvalin A. Transplantation (1978) 0.75
A controlled randomized double-blind study of antilymphoblast globulin in cadaver renal transplantation. Transplantation (1983) 0.75
Survival of rat heart allografts irradiated in vitro. Surg Forum (1971) 0.75
Interlamellar corneal grafts in rats. Effect of histocompatibility. Arch Ophthalmol (1975) 0.75
Low-dose maintenance prednisone and antilymphoblast globulin for the treatment of acute rejection. A steroid-sparing approach to immunosuppressive therapy. Transplantation (1983) 0.75
Modifying the immunogenicity of cell membrane antigens. Tumors and transplants. Am J Clin Pathol (1975) 0.75
Two-color immunofluorescence flow cytometric analysis of lymphocytes in long-term renal allograft recipients. J Urol (1989) 0.75
Further studies on the use of mouse epidermal cells for the in vitro induction and detection of cell-mediated cytotoxicity. Cell Immunol (1979) 0.75
Culturing before a transplant. Science (1981) 0.75
Brief communication: Effects of chronic cyclophosphamide and methotrexate treatment on skin allograft survival in mice and rats. J Natl Cancer Inst (1973) 0.75
Pretransplant donor specific blood transfusions for one haplotype stimulatory mixed lymphocyte culture living related donor transplants. Am J Kidney Dis (1982) 0.75
Influence of HLA AB and DR antigen matching in transfused cadaver renal transplant patients. Cleve Clin Q (1983) 0.75
Cell-mediated cytotoxicity to nonmajor histocompatibility complex alloantigens on mouse epidermal cells. V. Contribution of bone marrow-derived cells to Epa-1 antigen expression. Transplantation (1983) 0.75
Extended cadaver renal preservation with combined simple cold storage and hypothermic pulsatile perfusion. J Urol (1983) 0.75
Evidence of skin-specific alloantigens in cell-mediated cytotoxicity reactions. Transplant Proc (1980) 0.75
Bone marrow transplantation in clinical hematology. Mayo Clin Proc (1982) 0.75
A prospective analysis of the accuracy and cost-effectiveness of digital subtraction angiography for living-related renal donor evaluation. Transplantation (1986) 0.75
Simultaneous structural and functional imaging of the transplant kidney using digital subtraction angiography. J Urol (1983) 0.75
Factors responsible for the differential survival of heart and skin allografts in inbred rats. Transplantation (1973) 0.75
Expression of I-region gene products on mouse tail epidermis cells. Cell Immunol (1979) 0.75
Renal transplantation of patients on chronic peritoneal dialysis. Am J Kidney Dis (1984) 0.75
Regeneration following orthotopic peripheral nerve transplantation in inbred rats. Surg Forum (1973) 0.75
Monoclonal antibodies to tissue-restricted autoantigens in the mouse epidermis. Hybridoma (1988) 0.75
Cell-mediated cytotoxicity to non-MHC alloantigens on mouse epidermal cells. VI. Influence of the MHC on the tissue specificity of cytotoxic T-lymphocyte responses. Immunogenetics (1982) 0.75
Prolonged kidney allograft survival in the (Lewis x BN)F1 to Lewis strain combination. Transplantation (1977) 0.75
Evidence of cell-mediated cytotoxicity to skin-specific alloantigens on mouse epidermal cells. Transplant Proc (1981) 0.75
Epidermal cells as targets and stimulators of allograft immunity in vitro. Transplant Proc (1977) 0.75
Methods for induction of permanent graft survival. Transplant Proc (1979) 0.75
Domination by epidermal cell-reactive autoantibodies in attempts to raise antibodies to Epa-1 alloantigens. Transplantation (1988) 0.75
Results of transplantation with remote-positive proximate-negative T cell antiglobulin crossmatches. Transplant Proc (1987) 0.75
Preliminary clinical experience with pretransplant assessment of renal viability by phosphorus-31 magnetic resonance spectroscopy (31P-MRS). Transplant Proc (1988) 0.75
Prolonged survival of rats receiving kidney allografts perfused with concanavalin A. Transplantation (1976) 0.75
Expression of cell-defined H-Y antigen on mouse epidermal cells. Transplantation (1984) 0.75
Use of cyclosporine pharmacokinetic profiles in an antibody induction protocol reduces early acute rejection rates in recipients of primary cadaveric renal allografts. Transplant Proc (1997) 0.75
A mouse is a murine but so is a rat, and related matters. Transplantation (1995) 0.75
Management of end stage polycystic kidney disease with renal transplantation. J Urol (1981) 0.75
Adoptive transfer. Methods Enzymol (1984) 0.75
Survival of dog kidney allografts after in vitro irradiation. Transplantation (1973) 0.75
Cyclosporine as initial treatment for first acute rejection episodes in renal transplantation. Transplant Proc (1986) 0.75
Failure to immunize specific pathogen-free BALB-c mice to C3Hf skin allografts with streptococcal antigen. Transplantation (1972) 0.75
Determinants of allograft survival in 100 consecutive cadaver kidney transplants. J Urol (1982) 0.75
The effect of incubation in vitro with triamcinolone acetonide on murine heart and skin allograft survival. Transplantation (1973) 0.75
Effect of initial versus delayed cyclosporine therapy in cadaveric renal transplant patients. Transplant Proc (1987) 0.75
Cell-mediated cytotoxicity to non-MHC alloantigens on mouse epidermal cells. III. Epidermal cell-specific cytotoxic T lymphocytes. J Immunol (1981) 0.75
Reinnervation after orthotopic grafting of peripheral nerve segments in inbred rats. Plast Reconstr Surg (1974) 0.75
Strain differences in the expression of the Epa-1-restricting element. J Immunogenet (1988) 0.75